September 21, 2026
SARS-CoV-2 damages the gut barrier, letting bacterial endotoxin trigger microglial activation and brain fog. Here's the mechanism and the evidence-based repair protocol for leaky gut long covid.
September 13, 2026
Black seed oil long covid recovery hinges on thymoquinone's multi-target action against NLRP3 inflammasome activation, NF-kB neuroinflammation, and mitochondrial redox failure. Here's the evidence and the protocol.
August 14, 2026
Post-viral cells often get locked in inefficient glycolysis instead of switching back to oxidative metabolism. Here's the HIF-1α/PDK4 mechanism behind the glycolytic trap, why it defines the PEM threshold in Long COVID and ME/CFS, and the emerging interventions targeting it.
July 25, 2026
Humanin is a mitochondrial-derived peptide that governs cell survival under stress. Emerging research links its post-viral collapse to Long COVID fatigue, PEM, and bioenergetic failure — here's the evidence, the mechanism, and the intervention landscape.
July 20, 2026
HBOT for Long COVID targets bioenergetic failure at the mitochondrial level — not just symptoms. The 2022 Efrati RCT showed significant cognitive improvements, increased cerebral blood flow, and durable neuroplastic remodeling. Here's the full clinical breakdown.
July 10, 2026
LDN for Long COVID brain fog is now an NIH priority. The 2026 RECOVER-TLC trial is enrolling 1,300 participants to generate FDA-grade evidence. Here's what the microglial suppression mechanism means for high-performing professionals who haven't fully recovered cognitively from COVID.
June 20, 2026
The NLRP3 inflammasome is now confirmed as the master molecular switch behind Long COVID neuroinflammation, brain fog, chronic fatigue, and mood dysregulation. A landmark 2026 study explains why — and what you can do about it right now.
June 15, 2026
Urolithin A activates PINK1/Parkin mitophagy to clear damaged mitochondria from exhausted immune cells — restoring naive CD8+ T cells and raising the PEM threshold. Here is the full mechanistic breakdown and protocol stack for Long COVID and ME/CFS recovery.
May 16, 2026
EBV reactivation and Long COVID microaggregates create a compounding dual-hit mechanism driving post-viral fatigue in finance professionals. Discover the 4-layer evidence-backed clinical protocol, including the 2026 Wick et al. data showing 78% improvement with combined antiviral and anti-thrombotic therapy.
April 21, 2026
Endothelial senescence Long COVID senolytics explained: how SARS-CoV-2 locks blood vessel cells into a toxic zombie state, drives microclots and brain fog, and what the emerging 4-layer senolytic protocol does about it.